Whitehawk Therapeutics Inc
WHWK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $7,145 | $7,239 |
| % Growth | – | -100% | -1.3% | – |
| Cost of Goods Sold | $5 | $0 | $760 | $15,137 |
| Gross Profit | -$5 | $0 | $6,385 | -$7,898 |
| % Margin | – | – | 89.4% | -109.1% |
| R&D Expenses | $14,345 | $48,809 | $8,788 | $14,347 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,196 | $5,940 | $12,815 | $11,051 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$14,347 |
| Operating Expenses | $19,541 | $54,749 | $21,603 | $11,051 |
| Operating Income | -$19,546 | -$54,749 | -$15,218 | -$18,949 |
| % Margin | – | – | -213% | -261.8% |
| Other Income/Exp. Net | $1,800 | $2,134 | $88,234 | $676 |
| Pre-Tax Income | -$17,746 | -$52,615 | $73,016 | -$18,273 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$17,746 | -$52,615 | $73,016 | -$18,273 |
| % Margin | – | – | 1,021.9% | -252.4% |
| EPS | -0.26 | -0.76 | 1.84 | -0.67 |
| % Growth | 65.8% | -141.3% | 374.6% | – |
| EPS Diluted | -0.26 | -0.76 | 1.83 | -0.67 |
| Weighted Avg Shares Out | 68,254 | 69,083 | 27,087 | 27,087 |
| Weighted Avg Shares Out Dil | 69,205 | 69,083 | 27,087 | 27,087 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,850 | $1,979 | $791 | $676 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $16 | $48 | $47 |
| EBITDA | -$17,741 | -$52,599 | -$15,170 | -$18,226 |
| % Margin | – | – | -212.3% | -251.8% |